It is worth mentioning that the expansion of myeloid cells, both in myeloproliferative diseases [40] and in response to dexamethasone treatment [41], has been linked to increases in microRNA (miR)-155, which is thought to primarily target SHIP [42]. Here, INPP5D is linked to myeloproliferative disorder.